• Please log in or register to access this feature.

Hepatology Elsewhere

You have free access to this content

Spontaneous bacterial peritonitis and pharmacologic acid suppression in patients with cirrhosis†

  1. Ruben Terg MD

Article first published online: 8 JAN 2013

DOI: 10.1002/hep.26098

Issue

Hepatology

Hepatology

Volume 57, Issue 1, pages 411–413, January 2013

Additional Information

How to Cite

Terg, R. (2013), Spontaneous bacterial peritonitis and pharmacologic acid suppression in patients with cirrhosis. Hepatology, 57: 411–413. doi: 10.1002/hep.26098

Author Information

  1. Consultant Professor of Gastroenterology and Hepatology, Universidad del Salvador Hospital de Gastroenterología Bonorino Udaondo Buenos Aires, Argentina

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 8 JAN 2013
  2. Article first published online: 8 JAN 2013
  3. Manuscript Accepted: 4 OCT 2012
  4. Manuscript Revised: 2 OCT 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (321K)

References

  • 1
    Pallarito K. How safe are popular reflux drugs? Experts debate evidence-linking acid-blockers to possible bone, heart problems. US News and World Report, November 4, 2009.
  • 2
    Gray S, LaCroix A, Larson J et al. Proton pump inhibitor use, hip fracture and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch Intern Med 2010; 170: 765-771.
  • 3
    Asseri M, Schroeder T, Kramer J, Zackula R. Gastric acid supression by proton pump inhibitors as a risk factor for Clostridium difficile associated diarrhea in hospitalized patients. Am J Gastroenterol 2008; 103: 2308-2313.
    Direct Link:
  • 4
    Laheij R, Sturkenboom M, Hassing R, Stricker B, Jansen J. Risk of community-acquired pneumonia and use of gastric acid-supressive drugs. JAMA 2004; 292: 1955-1960.
  • 5
    Campbell M, Obstein K, Reddy R, Yang YX. Association between proton pump inhibitors use and spontaneous bacterial peritonitis. Dig Dis Sci 2008; 53: 394-398.
  • 6
    Bajaj J, Zadvornova Y, Heuman D, Hefeezullah M, Hoffmann R, Sanyal A, et al. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic with ascites. Am J Gastroenterol 2009; 104: 1130-1134.
  • 7
    Choi E, Lee H, Kim K, Lee S, Eun J, Jang B, et al. Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites. Scand J Gastroenterol 2011; 46: 616-620.
  • 8
    Morencos F, de las Heras Castaço G, Ramos M, Lopez Arias M, Ledesma F, Pons Romero F. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1995; 40: 1252-1256.
  • 9
    Bauer T, Steibruckner B, Brinkmann F, Ditzen A, Schwacha, Aponte J, et al. Small intestinal bacterial overgrowth in patients with cirrhosis:prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol 2001; 96: 2962-2967.
    Direct Link:
  • 10
    Lombardo L, Foti M, Ruggia et al. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2010; 8: 504-508.
  • 11
    Law D, Pimentel M. Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS. Dig Dis Sci 2010; 55: 2302-2308.
  • 12
    Choung R, Ruff K, Malhotra A, Herrick L, Locke GR 3rd, Harmsen WS, et al. Clinical predictors of small intestinal bacterial overgrowth byduodenal aspirate culture. Alim Pharmacol Therapeut 2011; 33: 1059-1067.
    Direct Link:
  • 13
    Ratuapli S, Ellington T, O'Neill M, Umar S, Harris M, Foxx-Orestein A, et al. Proton pump inhibitors therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol 2012; 107: 730-735.
  • 14
    Zedwitz-Liebenstein K, Wenisch C, Patruta S, Parschalk B, Daxbock F, Graninger W. Omeprazole treatment diminished intra-and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Car Med 2002; 30: 1118-1122.
View Full Article (HTML) Get PDF (321K)